PART I . Overview We are transforming the way therapeutics and materials are discovered. Our differentiated, physics-based computational platform enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at a lower cost, compared to traditional methods. Our software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. We are applying our computational plat...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001490978-26-000010 | EDGAR | 130K words |
| 2025-02-26 | 2024-12-31 | 0001490978-25-000014 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001490978-24-000018 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0001490978-23-000024 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001564590-22-006713 | EDGAR | — |
| 2021-03-04 | 2020-12-31 | 0001564590-21-010727 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001564590-20-011182 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001490978-26-000068 | EDGAR | — |
| 2025-11-05 | 2025-09-30 | 0001490978-25-000117 | EDGAR | 76K words |
| 2025-08-06 | 2025-06-30 | 0001490978-25-000100 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001490978-25-000059 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001490978-24-000089 | EDGAR | — |
| 2024-07-31 | 2024-06-30 | 0001490978-24-000072 | EDGAR | — |
| 2024-05-01 | 2024-03-31 | 0001490978-24-000046 | EDGAR | — |
| 2023-11-01 | 2023-09-30 | 0001490978-23-000109 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0001490978-23-000090 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001490978-23-000048 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001490978-22-000012 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001564590-22-028010 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001490978-26-000067 | EDGAR | — |
| 2026-03-12 | 0001490978-26-000013 | EDGAR | 1K words |
| 2026-02-25 | 0001490978-26-000009 | EDGAR | — |
| 2025-11-05 | 0001490978-25-000116 | EDGAR | — |
| 2025-09-08 | 0001490978-25-000106 | EDGAR | — |
| 2025-08-06 | 0001490978-25-000099 | EDGAR | — |
| 2025-06-18 | 0001490978-25-000082 | EDGAR | — |
| 2025-05-20 | 0001193125-25-122800 | EDGAR | — |
| 2025-05-19 | 0001193125-25-122461 | EDGAR | — |
| 2025-05-07 | 0001490978-25-000058 | EDGAR | — |
87 total filings indexed. 58 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001490978 |
| Ticker | SDGR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.schrodinger.com |
| Listed | 2020-02-06 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SDGR (~200 tokens, structured JSON with cryptographic provenance)